Physician profile

Matthew Sieverding

General Practice (Dentist) · Cedar Rapids, IA

NPI 1184288276

$600.65

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$97.48
Gift$62.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Align Technology, INC. $450.22 2021-2024 Invisalign, Invisalign System - Lite
Ultradent Products INC $62.49 2024 Opalescence
Orapharma, A Division of Bausch Health US, LLC $48.20 2019-2022
Henry Schein, INC. $15.62 2022
Colgate Oral Pharmaceuticals, INC. $12.88 2023
Voco America INC. $11.24 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew Sieverding

$600.65

in general payments reported 2019-2025

Years
2019-2024
Top company
Align Technology, INC.

https://glasscript.com/doctor/6465182/matthew-sieverding

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.